Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

982 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 2018 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Intestinal Colic Drops

Lack of Processing Controls: Firm is voluntarily recalling all lots of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir, within expiry, due to lack of adequate controls during manufacturing.

Terminated Stability / shelf life MBi Distributing Inc. dba MBi Nutraceuticals D-0869-2018
Class II · Moderate risk

Nausea Drops

Lack of Processing Controls: Firm is voluntarily recalling all lots of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir, within expiry, due to lack of adequate controls during manufacturing.

Terminated Stability / shelf life MBi Distributing Inc. dba MBi Nutraceuticals D-0868-2018
Class II · Moderate risk

Teething Drops

Lack of Processing Controls: Firm is voluntarily recalling all lots of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir, within expiry, due to lack of adequate controls during manufacturing.

Terminated Stability / shelf life MBi Distributing Inc. dba MBi Nutraceuticals D-0867-2018
Class II · Moderate risk

Gericare Diocto Liquid

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 57896-403-16 D-0852-2018
Class II · Moderate risk

SDA Senna Syrup

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 66424-562-08 D-0851-2018
Class II · Moderate risk

Geritrex Senna Syrup

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 54162-007-08 D-0850-2018
Class II · Moderate risk

GeriCare Senna Syrup

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 57696-452-08 D-0848-2018
Class II · Moderate risk

RPC APAP Elixir

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 53807-129-16 D-0847-2018
Class II · Moderate risk

RPC Children's Non-Aspirin

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC NDC 53807-129-04 D-0845-2018
Class II · Moderate risk

RPC Senna Syrup

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

Terminated Microbial contamination RIJ Pharmaceutical LLC D-0844-2018
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6637-1 D-0863-2018
Class II · Moderate risk

Minivelle (estradiol transdermal system)

Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Terminated Packaging defect Noven Pharmaceuticals, Inc. NDC 68968-6610-1 D-0862-2018
Class II · Moderate risk

Loxapine Capsules

GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination

Terminated Cross-contamination Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-903-20 D-0823-2018
Class II · Moderate risk

Loxapine Capsules

GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination

Terminated Cross-contamination Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-902-20 D-0822-2018

Recalls by year